Ticker > Company >

Medico Remedies share price

Medico Remedies Ltd.

NSE: MEDICO BSE: 540937 SECTOR: Pharmaceuticals & Drugs  39.73 K   74   4

39.54
+0.32 (0.82%)
BSE: 05 Sep 04:01 PM

Price Summary

Today's High

₹ 41

Today's Low

₹ 38.86

52 Week High

₹ 79.78

52 Week Low

₹ 35

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

328.12 Cr.

Enterprise Value

340.86 Cr.

No. of Shares

8.3 Cr.

P/E

31.76

P/B

5.1

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  7.75

CASH

1.09 Cr.

DEBT

13.83 Cr.

Promoter Holding

62.59 %

EPS (TTM)

₹  1.24

Sales Growth

4.15%

ROE

17.58 %

ROCE

21.65%

Profit Growth

21.74 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year4.15%
3 Year7.64%
5 Year11.23%

Profit Growth

1 Year21.74%
3 Year28.01%
5 Year44%

ROE%

1 Year17.58%
3 Year17.61%
5 Year15.01%

ROCE %

1 Year21.65%
3 Year21.81%
5 Year18.13%

Debt/Equity

0.2214

Price to Cash Flow

67.07

Interest Cover Ratio

12.6562

CFO/PAT (5 Yr. Avg.)

0.304266734488731

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 62.59 0.00
Mar 2025 63.79 0.00
Dec 2024 66.83 0.00
Sep 2024 73.34 0.00
Jun 2024 73.34 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 28.0072065118613% for the Past 3 years.
  • Company has been maintaining healthy ROCE of 21.8107333333333% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 12.6562.
  • The company has an efficient Cash Conversion Cycle of 53.3256 days.
  • The company has a high promoter holding of 62.59%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.99202815446062.

 Limitations

  • The company has shown a poor revenue growth of 7.64194942655598% for the Past 3 years.
  • The company is trading at a high PE of 31.76.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 30.8 39.35 39.49 41.3 38.25
Total Expenditure 27.99 36.94 36.38 34.64 35.43
Operating Profit 2.81 2.41 3.11 6.66 2.83
Other Income 0.29 0.68 1.43 0.29 0.66
Interest 0.18 0.21 0.28 0.49 0.28
Depreciation 0.75 0.75 0.76 0.77 0.77
Exceptional Items 0 0 0 0 0
Profit Before Tax 2.18 2.13 3.5 5.7 2.43
Tax 0.6 0.58 0.88 1.36 0.62
Profit After Tax 1.58 1.56 2.62 4.34 1.82
Adjusted EPS (Rs) 0.19 0.19 0.32 0.52 0.22

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 122.39 121.02 140.44 144.92 150.94
Total Expenditure 117.15 113.69 130.96 132.01 136.52
Operating Profit 5.24 7.33 9.48 12.91 14.42
Other Income 1.03 2.03 4.09 2.13 3.27
Interest 0.92 0.66 0.75 0.82 1.16
Depreciation 1.65 2.22 2.72 2.88 3.03
Exceptional Items 0 0 0 0 0
Profit Before Tax 3.7 6.48 10.1 11.33 13.5
Tax 1.11 1.67 2.86 3.04 3.41
Net Profit 2.59 4.81 7.24 8.29 10.09
Adjusted EPS (Rs.) 0.31 0.58 0.87 1 1.22

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 4.15 16.6 16.6 16.6 16.6
Total Reserves 28.31 19.98 27.25 35.77 45.87
Borrowings 4.95 0.9 0.25 0.25 0.25
Other N/C liabilities 0.26 1.6 1.84 1.01 0.12
Current liabilities 37.95 39.57 43.15 44.58 58.93
Total Liabilities 75.62 78.65 89.08 98.21 121.77
Assets
Net Block 15.31 18.03 21.83 21.49 21.29
Capital WIP 0 0 0 0 0.36
Intangible WIP 0 0 0.07 0 0
Investments 0.11 0 0 0.2 0.2
Loans & Advances 1.72 1.54 0.85 0.61 0.95
Other N/C Assets 0 0.07 0.16 0.18 0.08
Current Assets 58.48 59.01 66.17 75.73 98.89
Total Assets 75.62 78.65 89.08 98.21 121.77
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 3.68 6.48 10.1 11.33 13.5
Adjustment 2.57 2.52 2.71 3.53 2.44
Changes in Assets & Liabilities -16.63 -1.34 -2.15 -9.26 -7.25
Tax Paid -0.93 -1.79 -2.5 -3.17 -3.8
Operating Cash Flow -11.31 5.86 8.17 2.44 4.89
Investing Cash Flow -16.96 -1.76 -6.6 -2.68 -3.46
Financing Cash Flow 18.28 -5.77 -1.82 -0.49 -0.52
Net Cash Flow -9.99 -1.67 -0.25 -0.73 0.91

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 73.34 73.34 66.83 63.79 62.59
haresh kapurlal mehta 20.76 20.76 20.76 20.76 20.22
harshit haresh mehta 11.47 11.47 11.47 11.47 10.99
priyal rishit mehta 6.27 6.27 6.27 4.19 4.19
rishit hareshbhai mehta 14.82 14.82 12.65 12.65 12.65
rita h mehta 10.40 10.40 8.23 8.23 8.05
shweta harshit mehta 8.75 8.75 7.42 6.49 6.49
harshit h mehta huf 0.87 0.87 0.02 - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 26.66 26.66 33.17 36.21 37.41
llp 0.86 0.99 1.17 - 1.14
rg huf - - - - 6.84
ravi goyal huf - 3.95 6.60 6.84 -
sanjay narendra bansal 1.50 1.50 - - -
vijaygopal parasram atal 2.08 2.08 - - -
ravi goyal (huf) . 3.95 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2022
Annual Report 2020
Annual Report 2019
Annual Report 2018

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q2FY24

Company News

Medico Remedies - Quaterly Results 8 Aug, 5:04 PM Medico Remedies - Quaterly Results 8 Aug, 5:04 PM Medico Remedies - Quaterly Results 8 Aug, 5:04 PM Medico Remedies informs about disclosure 23 Jun, 5:19 PM Medico Remedies commences work for new factory 16 May, 9:24 AM Medico Remedies - Quaterly Results 8 May, 4:24 PM Medico Remedies - Quaterly Results 8 May, 4:24 PM Medico Remedies - Quaterly Results 8 May, 4:24 PM Medico Remedies secures government order worth Rs 16.31 crore 8 Apr, 4:40 PM Medico Remedies informs about disclosure 11 Mar, 12:02 PM Medico Remedies informs about disclosures 5 Mar, 4:59 PM Medico Remedies informs about disclosures 20 Feb, 6:26 PM Medico Remedies informs about press release 7 Feb, 4:54 PM Medico Remedies - Quaterly Results 5 Feb, 3:53 PM Medico Remedies - Quaterly Results 5 Feb, 3:53 PM Medico Remedies - Quaterly Results 5 Feb, 3:53 PM Medico Remedies informs about postal ballot notice 3 Feb, 3:42 PM Medico Remedies informs about press release 28 Dec, 4:06 PM Medico Remedies informs about newspaper advertisements 28 Dec, 3:12 PM Medico Remedies informs about disclosure 5 Dec, 11:11 AM Medico Remedies informs about disclosure 20 Nov, 1:10 PM Medico Remedies - Quaterly Results 12 Nov, 11:52 AM Medico Remedies - Quaterly Results 12 Nov, 11:52 AM Medico Remedies - Quaterly Results 12 Aug, 5:18 PM Medico Remedies - Quaterly Results 12 Aug, 5:18 PM Medico Remedies - Quaterly Results 9 May, 5:15 PM Medico Remedies - Quaterly Results 9 May, 5:15 PM Medico Remedies - Quaterly Results 9 May, 5:15 PM Medico Remedies - Quaterly Results 12 Feb, 4:29 PM Medico Remedies - Quaterly Results 12 Feb, 4:29 PM Medico Remedies - Quaterly Results 12 Feb, 4:29 PM Medico Remedies informs about investor presentation 11 Jan, 2:46 PM Medico Remedies informs about disclosure 3 Nov, 12:42 PM Medico Remedies submits intimation of cancellation of inter-se transfer of shares 23 Oct, 2:53 PM Medico Remedies informs about newspaper publication 11 Aug, 1:50 PM Medico Remedies - Quaterly Results 10 Aug, 3:49 PM Medico Remedies - Quaterly Results 10 Aug, 3:49 PM Medico Remedies informs about newspaper publication 24 Jul, 12:41 PM Medico Remedies informs about press release 21 Jul, 12:13 PM Medico Remedies to foray into ointment manufacturing segment 15 May, 9:29 AM Medico Remedies - Quaterly Results 11 May, 7:56 PM Medico Remedies - Quaterly Results 11 May, 7:56 PM Medico Remedies submits board meeting intimation 3 May, 4:49 PM Medico Remedies - Quaterly Results 10 Feb, 5:23 PM Medico Remedies - Quaterly Results 10 Feb, 5:23 PM Medico Remedies informs about board meeting 14 Jan, 11:22 AM Medico Remedies informs about trading window closure 27 Dec, 3:02 PM Medico Remedies - Quaterly Results 12 Nov, 9:24 PM Medico Remedies informs about newspaper advertisement 30 Aug, 4:52 PM Medico Remedies informs about RPT disclosures 16 Aug, 4:28 PM

Medico Remedies Stock Price Analysis and Quick Research Report. Is Medico Remedies an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Medico Remedies. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Medico Remedies has a PE ratio of 31.7053578600691 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Medico Remedies has ROA of 9.1765% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Medico Remedies has a Current ratio of 1.6781.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Medico Remedies has a ROE of 17.5779%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Medico Remedies has a Debt to Equity ratio of 0.2214 which means that the company has low proportion of debt in its capital.

  • Sales growth: Medico Remedies has reported revenue growth of 4.154% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Medico Remedies for the current financial year is 9.55414941099385%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Medico Remedies is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Medico Remedies is Rs 1.2449. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Medico Remedies in Ticker for free. Also, one can get the intrinsic value of Medico Remedies by using Valuation Calculators, which are available with a Finology ONE subscription. 

Medico Remedies FAQs

Q1. What is Medico Remedies share price today?
Ans: The current share price of Medico Remedies is Rs 39.47.

Q2. What is the market capitalisation of Medico Remedies?
Ans: Medico Remedies has a market capitalisation of Rs 327.537848 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Medico Remedies?
Ans: The PE ratio of Medico Remedies is 31.7053578600691 and the P/B ratio of Medico Remedies is 5.09494120228737, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Medico Remedies share?
Ans: The 52-week high share price of Medico Remedies is Rs 79.83, and the 52-week low share price of Medico Remedies is Rs 37.18.

Q5. Does Medico Remedies pay dividends?
Ans: Currently, Medico Remedies does not pay dividends. Dividend yield of Medico Remedies is around 0%.

Q6. What are the face value and book value of Medico Remedies shares?
Ans: The face value of Medico Remedies shares is Rs 2, while the book value per share of Medico Remedies is around Rs 7.7469. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Medico Remedies?
Ans: Medico Remedies has a total debt of Rs 13.8324 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Medico Remedies?
Ans: The ROE of Medico Remedies is 17.5779% and ROCE of Medico Remedies is 21.6538%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Medico Remedies a good buy for the long term?
Ans: The Medico Remedies long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Medico Remedies undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Medico Remedies appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Medico Remedies’s financials?
Ans: You can review Medico Remedies’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Medico Remedies
X